Nicoderm cq and Hair loss - a phase IV clinical study of FDA data


Hair loss is found among people who take Nicoderm cq, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Nicoderm cq and have Hair loss. It is created by eHealthMe based on reports of 17,449 people who have side effects when taking Nicoderm cq from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 30, 2022

17,449 people reported to have side effects when taking Nicoderm cq.
Among them, 50 people (0.29%) have Hair loss.

What is Nicoderm cq?

Nicoderm cq has active ingredients of nicotine. It is often used in quit smoking. eHealthMe is studying from 17,567 Nicoderm cq users for its effectiveness, alternative drugs and more.

What is Hair loss?

Hair loss is found to be associated with 3,705 drugs and 3,258 conditions by eHealthMe.

Number of Nicoderm cq and Hair loss reports submitted per year:

Could Nicoderm cq cause Hair loss?

Time on Nicoderm cq when people have Hair loss *:

  • < 1 month: 50 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 50 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Hair loss when taking Nicoderm cq *:

  • female: 95.65 %
  • male: 4.35 %

Age of people who have Hair loss when taking Nicoderm cq *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 5.71 %
  • 30-39: 14.29 %
  • 40-49: 22.86 %
  • 50-59: 25.71 %
  • 60+: 31.43 %

Common drugs people take besides Nicoderm cq *:

  1. Lantus: 9 people, 18.00%
  2. Metformin: 8 people, 16.00%
  3. Amlodipine: 8 people, 16.00%
  4. Diflucan: 7 people, 14.00%
  5. Proair Hfa: 6 people, 12.00%
  6. Nitrostat: 5 people, 10.00%
  7. Sertraline: 5 people, 10.00%
  8. Neosar: 5 people, 10.00%
  9. Tylenol: 5 people, 10.00%
  10. Naprosyn: 5 people, 10.00%

Common side effects people have besides Hair loss *:

  1. Urinary Tract Infection: 7 people, 14.00%
  2. Stress And Anxiety: 6 people, 12.00%
  3. Weakness: 5 people, 10.00%
  4. Fatigue (feeling of tiredness): 5 people, 10.00%
  5. Pain: 5 people, 10.00%
  6. Pneumonia: 4 people, 8.00%
  7. Headache (pain in head): 4 people, 8.00%
  8. Otitis (ear infection): 4 people, 8.00%
  9. Pulmonary Oedema (fluid accumulation in the lungs): 4 people, 8.00%
  10. Itching: 4 people, 8.00%

Common conditions people have *:

  1. Pain: 3 people, 6.00%
  2. Breast Cancer Female: 3 people, 6.00%
  3. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 3 people, 6.00%
  4. Multiple Myeloma (cancer of the plasma cells): 2 people, 4.00%
  5. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 4.00%
  6. Wheezing (a high-pitched whistling sound made while you breath): 1 person, 2.00%
  7. Depression: 1 person, 2.00%
  8. Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 2.00%
  9. Basal Cell Carcinoma (a skin cancer, it rarely metastasizes or kills): 1 person, 2.00%
  10. Breast Cancer: 1 person, 2.00%

* Approximation only. Some reports may have incomplete information.

Do you take Nicoderm cq and have Hair loss?

Check whether Hair loss is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

How severe was Hair loss and when was it recovered:

Expand to all the drugs that have ingredients of nicotine:

Alternative drugs to, pros and cons of Nicoderm cq:

Common Nicoderm cq side effects:

Browse all side effects of Nicoderm cq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Hair loss treatments and more:

COVID vaccines that are related to Hair loss:

Common drugs associated with Hair loss:

All the drugs that are associated with Hair loss:

Common conditions associated with Hair loss:

All the conditions that are associated with Hair loss:

How the study uses the data?

The study uses data from the FDA. It is based on nicotine (the active ingredients of Nicoderm cq) and Nicoderm cq (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: